Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Eli Lilly Says Phase III Study Of Cialis Meets Primary Endpoint - Quick Facts

Eli Lilly & Co (LLY: Quote) Tuesday announced that a Phase III study showed both Cialis and tamsulosin significantly improved scores on the International Prostate Symptom Score, compared to placebo, in men with signs and symptoms suggestive of benign prostatic hyperplasia, or BPH.

The randomized, double-blind, placebo-controlled, parallel-group, 12-week trial, conducted in 44 urology centers in 10 countries, assessed the efficacy and safety of Cialis 5 mg for daily use in parallel with tamsulosin 0.4 mg in men aged 45 years and older with signs and symptoms of BPH.

The company stated that Cialis improved erectile dysfunction in those men who had both signs and symptoms of BPH and ED.

The study also showed that maximum urinary flow rate increased significantly versus placebo with both Cialis and tamsulosin.

Click here to receive FREE breaking news email alerts for Eli Lilly And Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Bank of England policymakers decided to leave its key rate at a historic low of 0.50 percent in a split vote for the third straight time at the meeting held early this month as a majority of members noticed increased risks from slowing global economy, especially in euro area. Ian McCafferty and Martin Weale sought a quarter point hike in the bank rate, to 0.75 percent. European Central Bank Governing Council member Luc Coene said the central bank could expand its stimulus measures to purchasing instruments other than covered bonds and asset-backed securities, but there is no concrete proposal on corporate bonds, currently. In an interview published in Belgian dailies... Denis Mukwege, a doctor from the Democratic Republic of Congo, has won this year's Sakharov Prize for Freedom of Thought for helping thousands of gang rape victims in the country. The award was instituted by the European Parliament, and the laureate for 2014 was selected by EP President Martin Schulz and the political group leaders. Announcing Europe's top human rights prize Tuesday, Schulz said
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.